Literature DB >> 23483025

Morphologic analysis of pulmonary neuroendocrine tumors.

Seung Seok Lee1, Myunghee Kang, Seung Yeon Ha, Jungsuk An, Mee Sook Roh, Chang Won Ha, Jungho Han.   

Abstract

BACKGROUND: Few studies on how to diagnose pulmonary neuroendocrine tumors through morphometric analysis have been reported. In this study, we measured and analyzed the characteristic parameters of pulmonary neuroendocrine tumors using an image analyzer to aid in diagnosis.
METHODS: Sixteen cases of typical carcinoid tumor, 5 cases of atypical carcinoid tumor, 15 cases of small cell carcinoma, and 51 cases of large cell neuroendocrine carcinoma were analyzed. Using an image analyzer, we measured the nuclear area, perimeter, and the major and minor axes.
RESULTS: The mean nuclear area was 0.318±0.101 µm(2) in typical carcinoid tumors, 0.326±0.119 µm(2) in atypical carcinoid tumors, 0.314±0.107 µm(2) in small cell carcinomas, and 0.446±0.145 µm(2) in large cell neuroendocrine carcinomas. The mean nuclear circumference was 2.268±0.600 µm in typical carcinoid tumors, 2.408±0.680 µm in atypical carcinoid tumors, 2.158±0.438 µm in small cell carcinomas, and 3.247±1.276 µm in large cell neuroendocrine carcinomas. All parameters were useful in distinguishing large cell neuroendocrine carcinoma from other tumors (p=0.001) and in particular, nuclear circumference was the most effective (p=0.001).
CONCLUSIONS: Pulmonary neuroendocrine tumors showed nuclear morphology differences by subtype. Therefore, evaluation of quantitative nuclear parameters improves the accuracy and reliability of diagnosis.

Entities:  

Keywords:  Atypical carcinoid tumor; Carcinoma, large cell; Carcinoma, neuroendocrine; Carcinoma, small cell; Pulmonary neuroendocrine tumor; Typical carcinoid tumor

Year:  2013        PMID: 23483025      PMCID: PMC3589604          DOI: 10.4132/KoreanJPathol.2013.47.1.16

Source DB:  PubMed          Journal:  Korean J Pathol        ISSN: 1738-1843


  8 in total

1.  Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability.

Authors:  Michael A den Bakker; Sten Willemsen; Katrien Grünberg; L Arnold Noorduijn; Matthijs F M van Oosterhout; Robert J van Suylen; Wim Timens; Bart Vrugt; Anne Wiersma-van Tilburg; Frederik B J M Thunnissen
Journal:  Histopathology       Date:  2010-02       Impact factor: 5.087

Review 2.  Neuroendocrine tumors of the lung: an update.

Authors:  Natasha Rekhtman
Journal:  Arch Pathol Lab Med       Date:  2010-11       Impact factor: 5.534

Review 3.  Treatment of pulmonary neuroendocrine tumours: state of the art and future developments.

Authors:  Cesare Gridelli; Antonio Rossi; Giuseppe Airoma; Roberto Bianco; Raffaele Costanzo; Bruno Daniele; Giovanni De Chiara; Giuseppe Grimaldi; Luciana Irtelli; Paolo Maione; Alessandro Morabito; Franco Vito Piantedosi; Ferdinando Riccardi
Journal:  Cancer Treat Rev       Date:  2012-07-19       Impact factor: 12.111

Review 4.  Lung tumors with neuroendocrine morphology. A perspective for the new millennium.

Authors:  D B Flieder; M F Vazquez
Journal:  Radiol Clin North Am       Date:  2000-05       Impact factor: 2.303

Review 5.  Pulmonary neuroendocrine neoplasms: a review of clinicopathologic and cytologic features.

Authors:  Momin T Siddiqui
Journal:  Diagn Cytopathol       Date:  2010-08       Impact factor: 1.582

Review 6.  Neuroendocrine tumors of the lung: recent developments in histopathology.

Authors:  Douglas B Flieder
Journal:  Curr Opin Pulm Med       Date:  2002-07       Impact factor: 3.155

7.  Interobserver variability in diagnosing high-grade neuroendocrine carcinoma of the lung and comparing it with the morphometric analysis.

Authors:  Seung Yeon Ha; Joungho Han; Wan-Seop Kim; Byung Seong Suh; Mee Sook Roh
Journal:  Korean J Pathol       Date:  2012-02-23

Review 8.  Lung tumors with neuroendocrine morphology: essential radiologic and pathologic features.

Authors:  Teri J Franks; Jeffrey R Galvin
Journal:  Arch Pathol Lab Med       Date:  2008-07       Impact factor: 5.534

  8 in total
  2 in total

1.  Morphologic alteration of metastatic neuroblastic tumor in bone marrow after chemotherapy.

Authors:  Go Eun Bae; Yeon-Lim Suh; Ki Woong Sung; Jung-Sun Kim
Journal:  Korean J Pathol       Date:  2013-10-25

2.  Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.

Authors:  Young Bae Choi; Go Eun Bae; Na Hee Lee; Jung-Sun Kim; Soo Hyun Lee; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo
Journal:  J Korean Med Sci       Date:  2015-07-15       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.